Malignant vasovagal syncope: A randomised trial of metoprolol and clonidine

Heart

Volumn 77, Issue 3, 1997, Pages 268-272

  Biffi, Mauro ^a   Boriani, Giuseppe ^a   Sabbatani, Paolo ^a   Bronzetti, Gabriele ^a   Frabetti, Lorenzo ^a   Zannoli, Romano ^a   Branzi, Angelo ^a   Magnani, Bruno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Clonidine; Head up tilt test; Neurocardiogenic syncope; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; METOPROLOL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEAD TILTING; HUMAN; HYPOTENSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

EID: 0031000950     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.3.268     Document Type: Article

References (27)

1. Weissler AM, Warren JV. Syncope: pathophysiology and differential diagnosis. In: Hurst JW, Logue RB, Rackley CE, et al, eds. The heart. New York: McGraw Hill, 1986:507-29.
2. Kapoor WN. Diagnostic evaluation of syncope. Am J Med 1991;90:91-106.
3. Sutton R. Vasovagal syncope: clinical presentation, classification and management. In: Aubert AE, Ector H, Stroobandt R, eds. Cardiac pacing and electrophysiology. A bridge to the 21st century. Dordrecht: Kluwer, 1994:15 22.
4. Sra JS, Jazayeri MR, Avitall B, Akhtar M. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-90.
5. Sra JS, Murthy VS, Jazayeri MR, Shen Y-H, Troup PJ, Avitall B, et al. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992; 19:402-8.
6. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-81.
7. Milstein S, Beutikofer J, Dunnigan A, Benditt DG, Gomick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990;65:1339 44.
8. Fitzpatrick AP, Ahmed R, Williams S, Sutton R. A randomized trial of medical therapy in "Malignant Vasovagal Syndrome" or "Neurally-mediated Bradycardia/ Hypotension Syndrome". Eur J Cardiac Pacing Electrophysiol 1991;2:99-102.
9. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Astle LW. The usefulness of head-up tilt testing and hemodynamic investigation in the workup of syncope of unknown origin. PACE 1988;11:1202 14.
10. Sra JS, Anderson AJ, Sheikh SH, Avitall B, Tehan PS, Tromp PS, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013 9.
11. Grubb BP, Gerard G, Roush K, Temesy-Armus P, Elliot L, Hahn H, et al. Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern Med 1991,115:871 6.
12. Grubb BP, Temesy-Armus P, Hahn H, Elliot L. Utility of up-right tilt table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991; 90:6 10.
13. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 1983;74: 193-9.
14. Sutton R, Petersen MEV, Brignole M, Raviele A, Menozzi C, Giarri P. Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;2: 109-13.
15. Chen XC, Chen MY, Remole S, Kobayashi Y, Dunnigan A, Milstein S, et al. Reproducibility of head-up tilt table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 1992;69:755-60.
16. Sheldon R, Spalwinski J, Killman S. Reproducibility of iso-proterenol tilt table test results in patients with syncope. Am J Cardiol 1992;69:1300-5.
17. Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliot L. Reproducibility of head-upright tilt table results in patients with syncope. PACE 1992;15:1477 81.
18. Natale A, Akhtar M, Jazayeri M, Jazayeri M, Dhala A, Blanck Z, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995;92:54-8.
19. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93: 973-81.
20. Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992;69:904-8.
21. Hjorth S. Penbutalol as a blocker of central 5-HY1A receptor mediated responses. Eur J Pharmacol 1992;222: 121-7.
22. Hjorth S, Sharp T. In vivo microdialysis evidence for central serotonin1A and 1B autoreceptor of the beta receptor antagonist penbutalol. J Pharmacol Exp Ther 1993;265: 707-12.
23. Baum T, Shropshire AT. Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan in centrally administered 5-hydroxytryptamine. Neuropharmacology 1975;14:227-33.
24. Tadepelli A, Mills E, Schanberg S. Central depressor of carotid baroreceptor pressor response, arterial pressure and heart rate by 5-hydroxytryptophan: influence of the supramolecular areas of the brain. J Pharmacol Exp Ther 1977;202:310-9.
25. Grubb BP, Kosinski DJ. Serotonin and syncope: an emerging connection? Eur J Cardiac Pacing Electrophysiol 1995; 5:306-14.
26. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-3.
27. Dangovian HI, Jarandilla R, Frumin H. Prolonged asystole during head-up tilt table testing after beta-blockade. PACE 1992;15:14-16.